New therapies / indications available since the last 12 months
OPSUMIT®
TRESIBA®
CAPVAXIVE®
DATROWAY®
ITOVEBI®
GADOVIST®
PRIMOVIST®
HERNEXEOS®
HYCAMCORD®
Feb 11, 2026
BLENREP®
Apr 28, 2026
EMBLAVEO®
HEPWIN®
Dec 19, 2025
The Immune Reset Revolution: CAR T-Cell Therapy Takes Centre Stage at EULAR 2026
Dr. Feng Xue
A Silent Killer No More: How New Discoveries Are Changing Pancreatic Cancer Outcomes
Hope in Motion: Clinical Progress and Social Support for Parkinson’s
Andrew Chan
Uncovering the Tricks of the Silent Thief of Sight
Dr. Roy Lau
What’s New in Coronary Artery Disease?
Challenges and Strategies for Managing CHB Patients with Co-morbidities
.png)
